Navigation Links
BioSpain 2014 Expands its Investment Forum Through Wider Range of Investor Profiles and more Participating Companies
Date:7/16/2014

MADRID, July 16, 2014 /PRNewswire/ --


Biospain 2014 is currently seeking and selecting projects for presentation as part of its Investment Forum, one of the most high profile in the sector, for which 25 investment funds - 70% of which are international- have already confirmed their attendance, a figure the organisers expect to double.

     (Logo: http://photos.prnewswire.com/prnh/20140716/697032)

This year the Forum will be bolstered by the presence of a wider range of investor profiles, a bigger international presence and more participating companies.  

There are currently 10 available slots for companies and other entities wishing to pitch a business plan to the attending investors. In total, there will be 40 presentations over the three day duration of Biospain, each lasting 8-10 minutes, with alternating conferences on a wide range of investment issues (including corporate funds for big pharma, large international funds, PPP initiatives, business angels, industrial capital from non-pharma sectors and crowdfunding, to name a few).    

Among the most important funds to attend Biospain feature companies such as Aravis Ventures (Switzerland), Caixa Capital Risc (Spain), Cross Road Biotech (Spain), Edmond de Rothschild Investment  Partners (France), Forbion Capital Partners (Netherlands), Index Ventures (Switzerland), Johnson & Johnson Development Corporation (UK), LG Life Sciences (South Korea), Merck Serono Ventures (Germany), Novartis Venture Fund (Switzerland), Sofinnova Partners (France), Takeda Ventures (US), Ysios Capital Partners (Spain), Glaxo SmithKline Pharmaceuticals (UK) y Warburg Pincus (UK).

BioSpain 2014 (http://www.biospain2014.org), the 7th International Biotechnology Conference, is a biennial event which will take place from the 24th to the 26th of September in the Palacio de Congresos y Exposiciones de Galicia (Galicia Conference Centre), Santiago de Compostela (A Coruña). It is organised by the Spanish Bioindustry Association (ASEBIO) and on this edition, also by the Autonomous Government of Galicia, the University of santiago de Compostela, the University of Vigo and Santiago City Council.

Stand space at the trade fair is experiencing high demand, with 80% already allocated to exhibitors.  

So far we can confirm the attendance of over 100 companies and other entities from 20 countries, including delegations from countries such as PortugalCanadaColombiaMexicoRussia, the UK and India. Biospain expects to attract 2000 participants - 10% more than in 2012 - exceeding the benchmark set that year of 800 companies and institutions from 40 countries.

BioSpain 2014 is sponsored by Bioibérica, Merck, MSD, Zeltia Group, Roche Institute and CLAMBER (Castilla La Mancha Bioeconomy Region).

Lucía Cecilia
Head of Communications for BioSpain 2014 and ASEBIO
landline. + 34-912109374/10
mobile: + 34-663 117-293    
e-mail: lcecilia@asebio.com / lcecilia@biospain2014.org



'/>"/>
SOURCE ASEBIO (Spanish Bioindustry Association)
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. BioSpain 2014 erweitert ihr Investoren-Forum durch breiter gestreute Investorenprofile und mehr teilnehmende Unternehmen
2. BioSpain 2014 amplia il proprio Investment Forum attraverso una più ricca gamma di profili di investitori e un maggior numero di aziende partecipanti
3. As Smartphone Usage Expands, Survey Says Nurses and Nursing Students Want Mobile Access to Credible Drug Data
4. BioSurplus Expands, Debuts New 8000 Square Foot Warehouse and Service Facility
5. RxAlly Expands National Network With Addition Of Nineteen Community Pharmacy Organizations Representing Over 2,000 Pharmacies
6. Clinical Interest in BioElectronics Products Expands to the Wound Care Market
7. S1 Biopharma Expands Focus to Include Male Sexual Health
8. PRA Expands Operations in Europe
9. USANA Health Sciences Expands Award-Winning Research and Development Team
10. Particle Sciences Expands its cGMP Capabilities with the Addition of Thin Films
11. Argus Expands Specialty Pharmacy with Amber Pharmacy Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... 2016  Avista Pharma Solutions ("Avista Pharma") announced today ... Financial Officer (CFO). Mr. Setzer is a finance and ... various roles within growing technology and life science companies. ... Executive Director of Finance at INC Research, a publicly ... . Previously, Mr. Setzer served as CFO of ...
(Date:2/8/2016)... Velano Vascular, a medical technology company transforming ... their practitioners, announced today that the company has raised ... the proceeds from this financing, an extension of a ... to support the development and commercialization of the company,s ... Philadelphia , and a number ...
(Date:2/8/2016)... Fla. , Feb. 8, 2016 Vestagen ... marketing high performance apparel for healthcare and other demanding ... Chief Executive Officer. He replaces Dale Pfost ... remains Chairman. Mr. Bold is also joining Vestagen,s Board ... a new class of active barrier technologies that combines ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... February 08, 2016 , ... Stephanie Hebert Insurance ... beginning of a new charity campaign. As part of their ongoing community involvement ... In the belief that children deserve a voice, and in the spirit of ...
(Date:2/8/2016)... ... February 08, 2016 , ... If you are feeling that your ... are not alone. According to the Center for Disease Control and Prevention (CDC), 34.9% ... diabetes and certain types of cancer, some of the leading causes of preventable death. ...
(Date:2/8/2016)... ... 08, 2016 , ... Local insurance agency Dennis Fuller & ... has initiated a fundraiser for a two year old little girl named Bella, ... To support this beautiful child who is facing life’s journey without her loving ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... While a significant number of women and men with eating disorders report a ... that best predicts the development of an eating disorder. , At the ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... excited to share this important news! AHCC and the Home Health and Hospice ... Clinic, CMS' designee for official ICD coding guidance and clarifications, to address concerns ...
Breaking Medicine News(10 mins):